中智药业(03737)发盈警，预期年度纯利下跌不少于70%

Core Viewpoint - Zhongzhi Pharmaceutical (03737) anticipates a decline of no less than 70% in net profit for the year ending December 31, 2025, compared to the year ending December 31, 2024, due to industry policy adjustments affecting short-term sales revenue [1] Group 1 - The company expects a significant drop in net profit for 2025, indicating potential challenges ahead [1] - The decline in profit is attributed to adjustments in industry policies that will impact sales revenue in the short term [1] - Despite the anticipated profit drop, the company plans to maintain its market investment efforts and actively seek new business growth opportunities [1]